Siga Technologies (SIGA) Cost of Revenue (2018 - 2025)
Siga Technologies (SIGA) posted Cost of Revenue of $1.0 million for Q3 2025, down 96.08% on a QoQ basis from $25.6 million in Q2 2025, and down 38.16% year-over-year from $1.6 million in Q3 2024.
Siga Technologies (SIGA) Cost of Revenue (2018 - 2025) Analysis & Trends
Siga Technologies' Cost of Revenue history runs 8 years deep, the most recent figure standing at $1.0 million for Q3 2025.
- Quarterly Cost of Revenue fell 38.16% year-over-year to $1.0 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $40.8 million (up 27.8% YoY) and the FY2024 annual result came in at $31.3 million, up 75.53% from the prior year.
- Cost of Revenue was $1.0 million for Q3 2025 at Siga Technologies, down from $25.6 million in the prior quarter.
- Across five years, Cost of Revenue topped out at $25.6 million in Q2 2025 and bottomed at $83276.0 in Q3 2021.
- A 5-year average of $5.4 million and a median of $1.2 million in 2023 frame the typical range for Cost of Revenue.
- Annual changes were most pronounced in 2021 — Cost of Revenue sank 98.5% — and 2022, when it surged 4642.03%.
- Siga Technologies' Cost of Revenue stood at $15.3 million in 2021, then tumbled by 94.23% to $881375.0 in 2022, then surged by 1579.64% to $14.8 million in 2023, then retreated by 4.54% to $14.1 million in 2024, then slumped by 92.91% to $1.0 million in 2025.
- Business Quant data shows SIGA's Cost of Revenue at $1.0 million in Q3 2025, $25.6 million in Q2 2025, and $157738.0 in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 2.01 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 641.00 Mn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | 2.59 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 133.40 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 2.36 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 13.80 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 586.00 Mn |
| 10 | Siga Technologies | 223.05 Mn | 68.08 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 1.00 Mn |
| Sep 30, 2025 | 1.00 Mn |
| Jun 30, 2025 | 25.55 Mn |
| Jun 30, 2025 | 25.55 Mn |
| Mar 31, 2025 | 157,738.00 |
| Mar 31, 2025 | 157,738.00 |
| Dec 31, 2024 | 14.13 Mn |
| Dec 31, 2024 | 14.13 Mn |
| Sep 30, 2024 | 1.62 Mn |
| Sep 30, 2024 | 1.62 Mn |
| Jun 30, 2024 | 12.31 Mn |
| Jun 30, 2024 | 12.31 Mn |
| Mar 31, 2024 | 3.23 Mn |
| Mar 31, 2024 | 3.23 Mn |
| Dec 31, 2023 | 14.80 Mn |
| Dec 31, 2023 | 14.80 Mn |
| Sep 30, 2023 | 896,537.00 |
| Sep 30, 2023 | 896,537.00 |
| Jun 30, 2023 | 974,420.00 |
| Jun 30, 2023 | 974,420.00 |